Recent studies have identified the role of PRPS in cancer, particularly in the context of gaining drug resistance to thiopurine and thioguanine cancer therapy in childhood acute lymphoblastic leukemia (ALL) (Table 2 and [30,31]). This evidence concerns the gene MSMB and cancer.